Latest pharmacotherapy options for benign prostatic hyperplasia.
about
ANO1 plays a critical role in prostatic hyperplasia.Efficacy of α-blocker in improving ureteral stent-related symptoms: a meta-analysis of both direct and indirect comparison.Comparative effects of Yi Jin Jing versus Tai Chi exercise training on benign prostatic hyperplasia-related outcomes in older adults: study protocol for a randomized controlled trialSilodosin: a review of its use in the treatment of the signs and symptoms of benign prostatic hyperplasia.Serenoa repens, selenium and lycopene to manage lower urinary tract symptoms suggestive for benign prostatic hyperplasia.Clinically Meaningful Improvements in LUTS/BPH Severity in Men Treated with Silodosin Plus Hexanic Extract of Serenoa Repens or Silodosin Alone.
P2860
Latest pharmacotherapy options for benign prostatic hyperplasia.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Latest pharmacotherapy options for benign prostatic hyperplasia.
@en
type
label
Latest pharmacotherapy options for benign prostatic hyperplasia.
@en
prefLabel
Latest pharmacotherapy options for benign prostatic hyperplasia.
@en
P2093
P2860
P50
P1476
Latest pharmacotherapy options for benign prostatic hyperplasia.
@en
P2093
Alessandro Serino
Andrea Russo
Andrea Salonia
Francesco Montorsi
Michele Colicchia
Rocco Damiano
P2860
P304
P356
10.1517/14656566.2014.955470
P407
P577
2014-08-28T00:00:00Z